The long-term development of the Vaccine Market depends heavily on evolving international trade laws and unified product quality benchmarks. As cross-border shipping of delicate biologics grows more complex, harmonizing regulatory frameworks across different jurisdictions is a top priority for trade bodies. Rising global health expectations, updated tracking rules for biological items, and...